AIM
WVE icon

Acrospire Investment Management’s Wave Life Sciences WVE Stock Holding History

Acrospire Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-164
Closed -$5K – 2452
2016
Q3 		$5K Buy
164
+153
+1,391% +$3.62K ﹤0.01% 1831
2016
Q2 		$0 Buy
+11
New +$171 ﹤0.01% 2308

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acrospire Investment Management's WVE Position: Q4 2016 in Review

Acrospire Investment Management sold out of Wave Life Sciences (WVE) in Q4 2016, closing a stake of 164 shares — an estimated $5K sold.

Acrospire Investment Management first reported a position in WVE in Q2 2016 and held it in 2 quarters. The position peaked at $5K in Q3 2016. 51 funds tracked by Wall St. Rank hold WVE as of Q4 2016.

  • Acrospire Investment Management reported no remaining Wave Life Sciences position as of Q4 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 164 Wave Life Sciences shares in Q4 2016, an estimated $5K.
  • Acrospire Investment Management first reported a position in Wave Life Sciences in Q2 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Wave Life Sciences position peaked at $5K in Q3 2016.
  • 51 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.